Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462325) titled 'Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease' on March 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Condition:
Coronary Heart Disease (CHD)
Coronary Artery Disease
Percutaneous Coronary Intervention (PCI)
Residual Inflammatory Risk
Post-PCI Syndrome
Intervention:
Drug: colchicine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: March 1, 20...